Tizanidne hydrochloride
- Product NDC
- 67296-1793
- 11-digit product format
- 672961793
- Labeler code
- 67296
- Product ID
- 67296-1793_d61ccfc4-b180-7066-e053-2995a90a6318
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidne Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA212196
- Marketing category
- ANDA
- Marketing start
- 2019-03-29
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1793-7 | Tizanidne hydrochloride | 15 in 1 BOTTLE | CAPSULE | 15 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1793 | TIZANIDNE HYDROCHLORIDE CAPSULE [REDPHARM DRUG, INC.] | 5 | Legacy NDC, 1 package rows | 20220123_afd7e738-9cf4-7937-e053-2995a90a55bc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1793-7 | 67296179307 | 15 CAPSULE in 1 BOTTLE (67296-1793-7) | 15 capsule | 2020-09-21 | 0000-00-00 | No | No | Current |